Journal of Allergy and Clinical Immunology

publication venue for

Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS 2024
Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study 2024
Trial Characteristics of Randomized Controlled Trials Evaluating Macrolides in Moderate and Severe Asthma: An AAAAI/ACAAI JTFPP Systematic Review 2024
Asthma Clinical Remission with Benralizumab in an Integrated Analysis of the Real-World XALOC-1 Study 2023
Cancer Risk With Topical Pimecrolimus and Tacrolimus For Atopic Dermatitis: Systematic Review and Bayesian Meta-Analysis 2023
Airway Hyperresponsiveness and Eosinophilic Airway Inflammation In Patients With Atopic Dermatitis 2022
Anaphylaxis Management by Location: data from the Cross-Canada Anaphylaxis Registry (C-CARE) 2022
Assessments of Histopathology In Skin of Patients With Allergic Asthma 2022
Comparisons Of Baseline Characteristics And Treatment Efficacy In Individuals With Refractory Or Unexplained Chronic Cough Enrolled In Phase 3 Trials Of Gefapixant 2022
Culturing of Bacterial Isolates from Skin of Pediatric Atopic Dermatitis Subjects 2022
Effect Of Benralizumab On Skin Responses To Intradermal Allergen Challenge In Patients With Moderate-To-Severe Atopic Dermatitis 2022
Expansion of a double-negative (CD27-IgD-) B cell population in the sputum of severe eosinophilic asthmatic patients 2022
Impact of COVID-19 Restrictions on Anaphylaxis Presentations to the Emergency Department 2022
Rhinovirus increases Moraxella catarrhalis adhesion to the respiratory epithelium 2022
The Role of Epinephrine, Antihistamines, and Steroids in the Management of Anaphylaxis: Data from the Cross-Canada Anaphylaxis Registry (C-CARE) 2022
Accumulation of Allergen-specific CD4+ T cells in the Airways after Segmental Allergen Challenge is Associated with Reduced Expression of T2 Chemoattractant Receptors on Allergen-specific CD4+ T cells in Blood 2021
Changes in food spending among food allergic families following the COVID-19 pandemic 2021
Consequences of the COVID-19 pandemic on grocery shopping habits of food allergic families 2021
Effect of Dupilumab Treatment on Blood Eosinophil Levels in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Eosinophilic Esophagitis (EoE), or Atopic Dermatitis (AD) 2021
Effect of Prescription Drugs on Anaphylaxis Severity and Symptoms 2021
Prednisolone Treatment Reduces Type 2 Inflammation In Skin Lesions Of Patients With Atopic Dermatitis 2021
Staphylococcus aureus Increases Rhinovirus Replication and Synergistically Enhances Cytotoxicity During Co-infection of the Airway Epithelium 2021
The Effect Of Prednisolone Treatment On Histopathological Outcomes In Skin Of Patients With Atopic Dermatitis 2021
The Effect of Benralizumab On Allergen-Induced Responses In Subjects With Mild Allergic Asthma 2021
Commensal Bacteria Contribute to Barrier Integrity of the Nasal Epithelium 2020
Immune thrombocytopenia (ITP) in the setting of hereditary angioedema with C1 inhibitor deficiency (HAE C1INH): a possible consequence of low C4 2020
Low Use of Epinephrine for the Treatment of Anaphylaxis in Restaurants 2020
The Economic Impact of Food Allergy (FA) in Canada 2020
Characterization Of Allergen Sensitization Patterns In Canadian Preschool Children With Severe Wheezing 2019
Co-Occurrence of C1 Esterase Inhibitor Deficiency and Autoimmune Disease: A Systematic Literature Review 2019
Correlation of Clinical Atopic Dermatitis Scores with Levels of Eosinophil Progenitors in Skin after Intradermal Allergen Challenge 2019
Enumeration of IL-17A/F Producing Innate Lymphoid Cells in Subjects with COPD 2019
Field Study of a Novel Synthetic Peptide Immunotherapy in Cat Allergic Patients 2019
Mast cell expression of IL-33, ST2 and TSLPR in the skin of atopic dermatitis post-allergen exposure 2019
Omalizumab in Patients with Severe Asthma and Persistent Sputum Eosinophilia 2019
PVX108 Peptide Immunotherapy Significantly Reduces Markers of Peanut-Induced Anaphylaxis in a Dose-Dependent Manner 2019
Sex Differences in Type 2 Innate Lymphoid Cells in Adult Asthmatics 2019
Short Course Of Oral Prednisolone Improves Physician Reported Clinical Scores and Patient Reported Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis 2019
Sputum and serum immunoglobulins in patients with asthma and recurrent neutrophilic bronchitis 2019
Sputum autoantibody-mediated macrophage dysfunction in severe eosinophilic asthmatics with recurrent infections 2019
The Prevalence of Food Allergy is Less Frequent in Vulnerable Populations in Canada 2019
The Prevalence of Food Allergy is Not Increasing in Canada 2019
Comparison of Fel d 1 and Fel d 4 levels in house dust samples from the Canadian CHILD birth cohort 2018
Elevated Eosinophil Lineage-Committed Progenitors In Skin Lesions Of Patients With Moderate-To-Severe Atopic Dermatitis 2018
Expression profile of IL-33/ST2 and TSLP/TSLP-R in the skin of atopic dermatitis post-allergen exposure 2018
Risk of Anaphylaxis Risk In Schools – A Systematic Review 2018
Type 2 Innate Lymphoid Cells and Eosinophil Progenitor Cells are Preferentially Increased in Lesional Skin of Subjects with Atopic Dermatitis 2018
Type 2 innate lymphoid cells expressing death receptor 3 are increased in airway of mild atopic asthmatic subject following allergen inhalation challenge 2018
Effectiveness of Targeted Food Elimination Diet in Management of Pediatric Eosinophilic Esophagitis (EoE): A Retrospective Review. 2017
Peanut Introduction, Sensitization and Allergy Development in an Unselected Canadian Cohort 2017
Role of Patch Testing in Assessing Allergic Risk of Orthopedic Implants: Pre-and-Post Surgery 2017
A Randomized Controlled Trial of an Educational Handbook for Parents of Children with Food Allergy 2016
Aeroallergen and Food Sensitization Patterns in Adults with Eosinophilic Esophagitis 2016
Allergen-Induced Increase in Group 2 Innate Lymphoid Cells in the Airways of Mild Asthmatics 2016
Ara h 1 Peptide Immunotherapy Protects Against Peanut-Induced Anaphylaxis in a Dose-Dependent Manner 2016
Characterization of Patients and Pattern of Sensitization at a New Mcmaster University Allergy and Dermatology Patch Test (ADPT) Clinic 2016
Epicutaneous Allergen Exposure Dose Determines Manifestation of Allergic Airway Disease in Mice 2016
Fel d 1 Peptide Immunotherapy Ameliorates Both Cat and Ovalbumin Responses, in a Dual Allergen Murine Model of Allergic Airways Disease 2016
Food Allergen Labeling and Purchasing Habits in the US and Canada 2016
Human Hemopoietic Progenitor Cell Toll-like and Thymic Stromal Lymphopoietin Receptor Expression and Function in Allergic Asthmatic Subjects 2016
Mepolizumab in COPD with Eosinophilic Bronchitis: A Randomized Clinical Trial 2016
Nasal and Pharyngeal Eosinophil Peroxidase Levels Represent Surrogate Biomarkers for the Presence of Lower Airway Eosinophils in Adults with Poorly Controlled Asthma 2016
Pathogenic Autoantibodies in Patients with Severe Asthma and Sputum Eosinophils 2016
Radial Immunodiffusion Method for Evaluation of C1-Esterase Inhibitor Function 2016
Retrospective Chart Review Examining the Clinical Utility and Cost of Component Resolved Diagnostics (CRD) for Peanut Allergy (PA) in 2015 2016
A Bell-Shaped Dose-Dependent Induction of Allergen-Specific Tetramer+ CD4 T Cells and Activated Lung ILC2s Following Epicutaneous Allergen Sensitization in HLA-DR4 Transgenic Mice 2015
Ara h 1 Peptide Immunotherapy Ameliorates Peanut-Induced Anaphylaxis 2015
Development of a Clinical Lab Assay for Assessment of Eosinophil Peroxidase in Sputum 2015
Eosinophil Peroxidase As an Autoimmune Target in Eosinophilic Airway Disorders 2015
Human Bronchial Epithelial Cell-Derived Factors from Severe Asthmatics Can Stimulate Local Eosinophilopoetic Responses 2015
Initial Evidence of Sustained Efficacy of House Dust Mite Synthetic Peptide Immuno Regulatory Epitopes 2 Years after a Short Course of Treatment in House Dust Mite (HDM) Allergic Subjects 2015
Microbiome Effects on Hematopoietic Eosinophil/Basophil Progenitor Phenotype: Implications for the Pathogenesis of Allergic Inflammation 2015
Multiple Cumulative Allergen Concentration Delivery for Nasal Allergen Challenge – a Refinement of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC) Protocol 2015
Persistent Treatment Effect with Grass Synthetic Peptide Immuno-Regulatory Epitopes in Grass Allergy Symptoms in an Environmental Exposure Unit Challenge after a Second Season of Natural Pollen Exposure 2015
Preferential Production of TNFα, Compared to IL-4 and IFNγ, By Differentiating Eosinophil-Basophil Cord Blood Progenitors 2015
The Contribution of Peptide-MHC Affinity to the Efficacy of Peptide Immunotherapy in a Murine Model of Allergic Airways Disease 2015
The Nasal Allergen Challenge Protocol of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Validation in a Clinical Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE) 2015
Thymic Stromal Lymphopoietin Secretion As a Function of Genotype 2015
Airway Tissue, But Not Luminal, Eosinophilia Is Related To The Magnitude Of Airway Hyperresponsiveness In a Transgenic Murine Model Of Cat Allergy 2014
Comprehensive Metabolomic Analysis Identifies Uric Acid As a Critical Mediator Of Peanut Sensitization 2014
Enhanced Thymic Stromal Lymphopoietin-Induced Eosinophil-Basophil Lineage Commitment In Atopic Individuals 2014
Environmental and Sociodemographic Factors Associated With Food Allergy: A Nested Case-Control Study 2014
Ex-Vivo Allergen Stimulation In Whole Blood: A Novel Approach For Evaluating Mechanisms Of Action Of Synthetic Peptide Immuno-Regulatory Epitopes 2014
IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-Basophil Differentiation Of Cord Blood CD34+ Progenitor Cells 2014
Microbiota Regulates Eosinophils In The Small Intestine 2014
Pediatric Eosinophilic Esophagitis: A 10-Year Experience At a Canadian Tertiary Care Centre 2014
Persistent Treatment Effect Achieved At One Year After Four Doses Of Der p Derived Synthetic Peptide Immuno-Regulatory Epitopes In An Exposure Chamber Model Of House Dust Mite Allergy 2014
Possession Of Epinephrine Auto-Injectors (EAI) In a Vulnerable Canadian Population With Food Allergies 2014
Pre-Natal and Early Life Predictors Of Atopy In Canadian Children: Results Of The Family Study 2014
Treatment With Synthetic Peptide Immuno-Regulatory Epitopes Derived From Grass Allergens Leads To a Substantial Reduction In Grass Allergy Symptoms In The Environmental Exposure Unit 2014
1. Two Year Persistent Treatment Effect Achieved After 4 Doses of Cat-Peptide Antigen Desensitization (Cat-PAD) in an Environmental Exposure Chamber (EEC) Model of Cat Allergy 2013
Anaphylaxis Deaths in Ontario: A Retrospective Review of Cases From 1986 to 2011 2013
Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD) 2013
Safety and Tolerability of Fel d 1-Derived Peptide Antigen Desensitization in Subjects with Controlled Asthma 2013
Strategies to Query and Display Allergy-Derived Epitope Data From the Immune Epitope Database (IEDB) 2013
The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC) – a Multicentre Pilot Study to Optimize a Standard Nasal Allergen Challenge Protocol 2013
Thymic Stromal Lymphopoietin Promotes Peripheral Blood CD34+ Cell Eosinophilic Lineage Commitment 2013
Bullying of Food-Allergic Youth: Results from a Parent and Child Survey 2012
Cord Blood (CB) Eosinophil/Basophil (Eo/B) Progenitors Predict Respiratory Outcomes Until The Age Of Two 2012
Experiencing a First Allergic Reaction to Food: A Qualitative Study of Parent And Caregiver Perspectives 2012
Inhibition of Eosinophil Differentiation in vitro by a PPARγ Agonist 2012
Mechanisms Of Tlr-mediated Cord Blood Cd34+ Progenitor Cell Eosinophil Differentiation: Signaling And Autocrine Pathways 2012
Overall Prevalence Of Self-reported Food Allergy In Canada 2012
Persistent Treatment Effect Achieved at One Year After 4 Doses of Fel d 1-Derived Peptide Immunotherapy in an Environmental Exposure Chamber (EEC) Model of Cat Allergy 2012
Prevalence of Common Food Allergies in Canada: Targeting Specific Demographic Groups across Canada 2012
Suppression of Allergic Airway Inflammation by Low Dose, Intranasally Administered Der p 1 Derived Peptides, in a Murine Model of House Dust Mite Allergy 2012
Development and Preliminary Clinical Evaluation of a Peptide Immunotherapy Vaccine for Cat Allergy 2011
Effect of Maternal Allergic Sensitization and Smoking during Pregnancy on Eosinophil- Basophil Lineage Commitment 2011
Efficacy of Reslizumab in Patients with Poorly Controlled Eosinophilic Asthma: Subgroup Analysis of Patients with Nasal Polyps 2011
Food Avoidance Following Physician Diagnosis Of Food Allergy: Results From A Canadian Study 2011
Impact of Precautionary Statements on Purchasing Practices of Canadians Directly and Indirectly Affected by Food Allergies 2011
Induction of Thymic Stromal Lymphopoietin (TSLP) in Airway Epithelium by Recombinant Allergens 2011
Sputum Hyaluronan as a Biomarker of Airway Remodeling in Severe Asthma 2011
TPI ASM8 Decreases Inflammatory Markers and Improves Airway Responsiveness in Asthmatics 2011
The Epithelial-derived Cytokines TSLP, IL-33, and IL-25 Converge on OX40L to Elicit Peanut Allergy and Anaphylaxis in Mice 2011
Cord Blood Eosinophil Progenitor Expression of Major Basic Protein mRNA is Associated with Maternal Atopic Sensitization 2010
Cord Blood Hemopoietic Progenitor Cell Toll-Like Receptor Expression and Function: A Mechanism Underlying Allergic Inflammation in Early Life 2010
Epinephrine auto-injectors (EAIs) in Canadians with Food Allergies 2010
Food Allergies in Canada: Prevalence and Associated Factors 2010
Significant Reduction In Combined Symptom And Medication Score Compared With Placebo With A Ragweed uSCIT Formulation For Seasonal Pollen Allergy 2009
A Comparative Analysis of Canadian School Board Anaphylaxis Management Policies 2009
A Double-blind, Placebo-controlled, Randomized, Crossover Trial Of a Mint Tea High In Rosmarinic Acid In Adults With Nasal Polyposis 2009
Concurrent Blockade of Platelet Activating Factor and Histamine Prevents Life-threatening Peanut-induced Anaphylactic Reactions 2009
Cord Blood (CB) Progenitor Toll- Like Receptor (TLR) Expression: An Alternate Innate Immune Pathway In The Development Of Atopy 2009
Cord Blood CD34 + Hemopoietic Progenitor Eosinophilic Lineage Commitment Assessed by Q-PCR 2009
Effector Function of CD34+ Hemopoietic Progenitor Cells in Allergic Inflammation 2009
Gaps in Anaphylaxis Management From the Physician, Patient, and Community Perspective: A Systematic Review of the Literature 2009
Precautionary Statements on Packaged Foods in Canada: Perspectives and Purchasing Behaviours of Allergic and Non-Allergic Consumers 2009
Significant Improvements In Quality Of Life Following MPL-Adjuvanted Ultra Short Course Subcutaneous Immunotherapy (uSCIT) In Patients With Seasonal Grass Pollen Allergy 2009
Cord Blood Progenitor Cell Toll-Like Receptor Expression: An Alternate Innate Immune Pathway in the Development of Atopy?. 2009
Changes in Upper and Lower Airway Inflammation Following Repeated Nasal Allergen Challenges in Rhinitic Subjects With or Without Asthma 2008
Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut 2008
Improving Food Labeling for the Allergic Consumer 2008
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge 2007
Understanding Immunological Pathways of Peanut-induced Anaphylaxis 2007
Allergies in Canada: AR Patient Perspectives on Prescription Nasal Sprays 2007
Burden of Illness of Allergic Rhinitis in Canada 2007
Kinetics of Cord Blood Eosinophil Lineage Biomarker mRNA: Co-expression of CysLTR1 with GATA-1 2007
Molecular Markers of Eosinophilopoiesis: Multiplex Q-PCR Analysis of GATA-1, MBP and IL-5 Receptor mRNA Expression in Peripheral Blood 2007
Montelukast Added to Usual Therapy during the September Epidemic of Asthma Exacerbations in Children 2007
Pharmacological Effects of ASM8, an Antisense Oligonucleotide to CCR3 and the Common Beta Chain Receptor in Mild Asthmatics 2007
Physicians' Perspectives of Allergic Rhinitis (AR) in Canada 2007
Airway Expression of Calcitonin Gene-Related Peptide in T-Cell Peptide-Induced Late Asthmatic Reactions 2006
Comparison of duality of life in dermal reactors referred to an out-patient clinic versus patients recruited by advertisement 2006
Expression of Cysteinyl Leukotriene Receptors by CD34+ Umbilical Cord Blood (CB) - Progenitor Cells: Relevance to Atopic Development 2006
Molecular Markers of Eosinophilopoiesis at Birth: Kinetics of Cord Blood GATA-1, MBP and IL-5 Receptor Expression 2006
Peptide Immunotherapy in Fel d 1-Sensitized HLA-DR1 Transgenic Mice is Associated with Increased IL-10 but Independent of TGFbeta and Foxp3 Expression 2006
Regulation Of IL-5Rα On Bone Marrow Eosinophils and CD34+ Progenitors 2006
Sex Differences in Effects of Breastfeeding on Asthma and Allergy in Relation to Parental Atopy 2006
The Effect of Lipopolysaccharide (LPS) on Cord Blood (CB) Hemopoietic Progenitor Cytokine Receptor Expression 2006
Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Efficacy of Immunotherapy 2006
Assessment of optimal depth to quantify fibrosis in mice airway 2002
Desensitization (“Tolerance”) induced by allergen-derived T cell peptide epitopes: Evidence for the induction of linked suppression 2002
Development and validation of the nocturnal rhinitis quality of life questionnaire 2002
Different mechanisms of airway hyperresponsiveness between mice subjected to brief or chronic exposure to allergen 2002
Effects of the cysteinyl leukotriene receptor antagonist, montelukast, on eosinophil differentiation in an experimental mouse model of allergic rhinitis 2002
Expression of GM-CSF in the airway drives Th2 differentiation and effector function in mice exposed to ragweed intranasally 2002
IL-10 inhibits allergen-specific TH2 cytokine production by human peripheral blood mononuclear cells from patients with ragweed allergies 2002
Inhalation of allergen-derived T cell peptide epitopes induces isolated late asthmatic reactions with associated local eosinophilia 2002
Insect venom allergy and the burden of the treatment (BoT): Epipen vs venom immunotherapy (VIT) 2002
Is IL-5 suppression sufficient to control eosinophilic airway allery?: Studies of experimental allergic rhinitis in IL-5 deficient mice 2002
Predicting in vivo aerosol delivery using simulated breathing patterns 2002
Repeatability and responsiveness of an airway morphometric technique in a mouse model of chronic allergen challenge 2002
T cell peptide epitope immunotherapy is accompanied by local increases in CD25+T cells 2002
The combined effect of all trans retinoic acid and the glucocorticoid, budesonide, on eosinophil differentiation from cord blood-derived CD34+ progenitor cells in vitro 2002
The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: A placebo-controlled randomized study 2002
The effectiveness of an asthma control questionnaire (ACQ) in predicting clinical decisions in an inhaled corticosteroid tapering protocol 2002
The utility of skin testing in patients with reactions to a meningitis vaccine (MV) 2002
Traffic of eosinophil-lineage committed progenitors to the lung tissue of sensitised mice following allergen challenge 2002
A dosing protocol of allergen-derived T cell peptide epitopes for the treatment of allergic disease 2001
A double-blind, placebo-controlled study of short peptides derived from Fel d1 in cat-allergic subjects 2001
Adding formoterol to budesonide in moderate asthmatics is cost saving - Results from the FACET Study 2001
Attenuation of cutaneous and bronchial late allergic reactions by short allergen-derived peptides is associated with a reduction in peptide and whole allergen-induced T cell effector function 2001
Bone marrow function in murine experimental allergic rhinitis: The role of IL-5 in eosinophil/basophil differentiation 2001
Bone marrow progenitors in chronic airway inflammation: Relationship to tissue inflammatory cells and cytokine expression in nasal polyposis 2001
Budesonide inhalation suspension improves quality of life in families of children with asthma 2001
Immunostaining for CD34 on human myeloid cells: Effect of sputum processing 2001
Increased numbers of eosinophils in bronchial biopsies of atopic asthmatics after LTE4 butnotLTD4 inhalation 2001
The effect of breastfeeding on the risk of atopy and asthma: A longitudinal cohort analysis 2001
The effect of the glucocorticoid, budesonide, on eosinophil differentiation from bone marrow CD34(+) progenitors in vitro 2001
Treatment with IFN gamma reverses airway pathophysiology in allergen-challenged IFN gamma deficient mice 2001
Upregulation of eotaxin receptor, CCR3, on bone marrow CD34+progenitor cells following allergen-inhalation challenge in asthmatic subjects: A mechanism of progenitor cell egress from the bone marrow during allergic inflammation 2001
Venom immunotherapy (VIT) improves health-related quality of life (HRQL) in patients with allergic reactions following yellow-jacket stings - Extended observations 2001
Carbon dioxide inhalation challenges in idiopathic environmental intolerance 2000
111 Attenuation of late cutaneous and asthmatic reactions following administration of short allergen-derived T cell peptide epitopes 2000
1132 Safety of fexofenadine HCI in asthmatic patients requiring inhaled corticosteroids in accordance with NHLBI guidlines 2000
227 Glucocorticoid enhancement of IL-5-induced bone marrow eosinophil progenitor colony formation in vitro 2000
305 A high dose of inhaled budesonide is more cost-effective than a low dose in moderate asthma 2000
382 Carbon dioxide inhalation challenges in idiopathic environmental intolerances 2000
452 Assessment of nasal polyp CD34+ progenitors: Relationship to GM-CSF expression and topical corticosteroids 2000
468 Induction of cutaneous and bronchial hyporesponsiveness by short allergen-derived peptides 2000
521 Increased numbers of eosinophil progenitor cells (CD34+IL5R?+) in the bone marrow of atopic asthmatic subjects 2000
752 Blood eosinophils from atopic donors express messenger RNA for the ?, ?, ?*, and ?* subunits of the high affinity IgE receptor (Fc?RI) and intracellular, but not cell surface, ? subunit protein 2000
753 Some pitfalls in measuring human eosinophil numbers in blood and tissues 2000
767 Modulation of eosinophil progenitor growth and IL5R? expression on CD34+ cells by retinoic acid 2000
825 Mechanisms of the late asthmatic reaction induced by IgE-independent MHC-restricted T cell peptide epitopes 2000
Circulating T-cells and granulocytes from asthmatics exhibit impaired capacity for intracellular IL-10 production. 1999
Clinical and immunologic characteristics associated with "growing out of asthma". 1999
Decreased Th-1 type cytokine expression by peripheral blood mononuclear cells (PBMC) is associated with "growing out of asthma". 1999
Development and validation of the Mini Rhino-conjunctivitis Quality of Life Questionnaire (MiniRQLQ). 1999
Development and validation of the standardized Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ(S)). 1999
Intramolecular variation in cytokine production profiles in allergic asthma: A comparison of allergen peptide-specific responses in defined clinical groups. 1999
Peptide-induced late asthmatic reactions following MHC-restricted T cell activation in vitro. 1999
The effects of inhaled budesonide on eosinophil progenitor cells following allergen inhalation in atopic asthmatics. 1999
The treatment of bilateral nasal polyposis with fluticasone propionate nasal drops. 1999
Impact of upper respiratory allergic diseases on quality of life 1998
Asthma provoked by T-cell peptide epitopes 1998
Clinical judgment of airway inflammation versus sputum cell counts in asthma. 1998
Development and validation of the standardised asthma quality of life questionnaire (AQLQ(S)). 1998
Dose-dependent increase in bone-marrow eosinophil content after repeated airway allergen exposure in sensitised mice. 1998
Effect of topical corticosteroids on CD34 immunoreactivity in nasal polyps. 1998
Experiences of a latex allergy work group. 1998
Expression of GM-CSF mRNA and product differentiating eosinophils in vitro. 1998
In vitro up-regulation of Fc epsilon RI on human peripheral blood eosinophils from atopic subjects. 1998
Induction of eosinophilic differentiation involves selective up-regulation of beta-7 integrin. 1998
Mapping of T cell epitopes of chain 1 Fel d 1 by primary peripheral blood mononuclear cell proliferation assays in cat allergic asthmatics, cat allergic rhinitics, non cat allergic asthmatics and normal controls. 1998
Rate of MMR associated reactions in patients following positive prick and intradermal testing. 1998
Retinoic acid selectively inhibits IL-5 receptor expression during differentiation of hemopoietic progenitor cells. 1998
A cost-benefit analysis of a medical therapy for seasonal allergic rhinitis. 1997
Bronchoalveolar lavage macrophages from atopic asthmatics, but not normal subjects, display CD86-dependent antigen presenting cell function, although CD86 is equally expressed by asthmatic and control macrophages. 1997
Cross-sectional validation of a specific instrument measuring Health Related Quality of Life (HRQL) in yellow jacket allergic patients. 1997
Dependence of allergen-induced T cell proliferation and cytokine production on CD28/B7 co-stimulation. 1997
Endogenous IL-10 production is a major regulator of IL-12 and IFN gamma expression in human peripheral blood mononuclear cell (PBMC) cultures. 1997
Expression of IL-4 and IL-5 mRNA and protein product by CD4(+) and CD8(+) T cells, eosinophils (Eos) and mast cells in bronchial mucosa of atopic (AA) and non-atopic (NAA) asthmatics. 1997
GM-CSF regulation by differentiating eosinophils after allergen challenge. 1997
Increased expression of IL-5 receptor alpha-subunit on bone marrow derived CD34(+) progenitors following allergen challenge in dual responder asthmatics. 1997
Inhaled allergen-induced changes in bone marrow eosinophil/basophil progenitors in mild asthmatic subjects. 1997
Intradermal GM-CSF gene transfer in rat induces skin pathologies similar to chronic atopic dermatitis. 1997
Maternal uterine T cell determination of survival of the fetus QUA parasite. 1997
Transepithelial antigen transport: Effect of sensitization and antigen challenge in normal and mast cell deficient rats. 1997
Both lymphocytes and monocytes contribute to the enhanced tumour necrosis factor-alpha (TNF-alpha) production by peripheral blood mononuclear cells (PBMC) of severe and mild atopic asthmatics. 1996
Development of a specific instrument to measure health related quality of life (HRQL) in hymenoptera allergic patients. 1996
Effect of a topical nasal steroid on GM-CSF, IL-6, IL-8 and HLA-D expression by nasal epithelial cells in seasonal allergic rhinitis (SAR). 1996
IL-5 secretion by allergen-specific CD4+ cells in shortterm culture: Dissociation from allergen-induced proliferation and dependence on B7-2 co-stimulation. 1996
Immunolocalization of stem cell factor in inflamed human nasal tissues. 1996
Increased bone marrow progenitor growth after allergen challenge in dogs depends on a serum factor 1996
Increases in circulating CD34(+) hemopoietic progenitors in allergen-induced late asthmatic responses 1996
The effects of inhaled prostaglandin E(2) on allergen-induced airway responses 1996
A DOUBLE-BLIND COMPARISON OF INTRANASAL BUDESONIDE DRY POWDER VS PLACEBO IN NASAL POLYPOSIS 1995
ELEVATED LEVELS OF CD34(+) HEMATOPOIETIC PROGENITOR CELLS IN ATOPIC SUBJECTS 1995
HUMAN NASAL POLYP FIBROBLASTS PRODUCE STEM-CELL FACTOR (SCF) 1995
INHALED BUDESONIDE, BUT NOT SALBUTAMOL, REDUCES ALLERGEN-INDUCED INCREASES IN CIRCULATING EOSINOPHILS AND THEIR PROGENITORS 1995
ISOLATION OF CANINE EOSINOPHILS USING A CROSS-REACTIVE ANTIBODY TO HUMAN CD15S 1995
LOCALIZATION OF INTERLEUKIN-4 IN EOSINOPHILS IN NASAL POLYPS AND ASTHMATIC BRONCHIAL-MUCOSA 1995
MEASURING QUALITY-OF-LIFE (QOL) IN CHILDREN WITH ASTHMA 1995
PROSTANOID ENHANCEMENT OF IL-6 PRODUCTION BY RAT PERITONEAL MAST-CELLS 1995
RHINOCORT(R) TURBUHALER(R) HAS EQUAL EFFICACY AND BETTER PATIENTS PREFERENCE THAN RHINOCORT(R) AQUA IN THE TREATMENT OF RAGWEED ALLERGIC RHINITIS 1995
STIMULATION OF CANINE BONE-MARROW GRANULOCYTE PROGENITOR GROWTH BY A SERUM FACTOR PRESENT 24 HOURS AFTER ALLERGEN INHALATION 1995
THE ALLERGEN-INDUCED LATE ASTHMATIC RESPONSE AS A MODEL TO TEST RELATIVE POTENCY OF INHALED CORTICOSTEROIDS 1995
THE INDUCTION OF PERIPHERAL-BLOOD MONONUCLEAR CELL TNF-ALPHA PRODUCTION BY IFN-GAMMA CAN BE INHIBITED BY BUDESONIDE 1995
TNF-ALPHA PRODUCTION INDUCED BY T-CELL SPECIFIC AND NONSPECIFIC STIMULI IS INCREASED IN ATOPIC ASTHMATICS 1995
A CONTROLLED TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR (RHU-IL-1R) FOR GRASS-POLLEN HAY-FEVER 1994
CYTOKINES AND HLA IMMUNOLOCALIZATION OF NASAL EPITHELIAL-CELLS 1994
EFFECT OF BUDESONIDE (B) ON THE SURVIVAL OF EOSINOPHILS (EO) FROM BOTH PERIPHERAL-BLOOD AND NASAL POLYP (NP) TISSUES 1994
EXPRESSION OF GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) DURING MATURATION OF EOSINOPHILS AND BASOPHILS 1994
INDUCTION OF SPUTUM USING INHALED HYPERTONIC SALINE WITH DIFFERENT NEBULIZERS 1994
MICROVASCULAR THROMBOSIS, LUPUS GLOMERULONEPHRITIS (GN) AND ACUTE-RENAL-FAILURE IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND ANTIPHOSPHOLIPID ANTIBODIES 1994
SEASONAL EXPOSURE IN RAGWEED ALLERGIC NASAL POLYP PATIENTS - 1) LACK OF SYMPTOMS, 2) MEASUREMENT OF POSSIBLE INHIBITORS, NASAL IL-8 AND SIL-1R 1994
SHEEPSKINS AND BEDDING IN CHILDHOOD, AND DEVELOPMENT OF BRONCHIAL-ASTHMA 1994
TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) EXPRESSION IS NOT RELATED TO MAST-CELL DEVELOPMENT FROM STEM-CELL FACTOR-STIMULATED HUMAN BONE-MARROW IN CULTURE 1994
AIRWAY RESPONSIVENESS RELATED TO ALLERGEN SKIN-TEST REACTIVITY 1993
ALLERGIC REACTION TO INJECTED ANTI-RH HUMAN-IMMUNOGLOBULIN PREPARATION 1993
ATOPY AND AIRWAY RESPONSIVENESS IN HAY-FEVER AND ASTHMA 1993
COMPARISON OF 2 METHODS OF SYMPTOM DOCUMENTATION FOR RESEARCH STUDIES 1993
GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) IN NASAL POLYPS (NP) AND TURBINATE MUCOSA AND EFFECTS OF TOPICAL STEROID 1993
ISOLATION OF AN ENRICHED ACTIVATED EOSINOPHIL (E-PHI) FRACTION FROM HUMAN NASAL POLYP (NP) TISSUES 1993
MODULATION OF HUMAN EOSINOPHIL CHEMOTAXIS AND ADHESION BY CETIRIZINE, INVITRO 1993
PARENTAL VERSUS CHILDS HISTORY IN THE DIAGNOSIS OF ASTHMA 1993
SERUM INTERLEUKIN-6 LEVELS IN CYSTIC-FIBROSIS PATIENTS AND HEALTHY CONTROLS AT REST AND AFTER HIGH-INTENSITY EXERCISE 1993
THE EFFECTS OF A 5-LIPOXYGENSAE INHIBITOR, ZILEUTON, ON OZONE-INDUCED AIRWAY HYPERRESPONSIVENESS IN DOGS 1993
THE EOSINOPHIL CHEMOTACTIC ACTIVITY OF INTERLEUKIN-8 1993
DEPLETION OF LYMPHOCYTES-T AND EOSINOPHILS (EO) IN NASAL POLYPS (NP) TREATED BY TOPICAL STEROID 1992
DEVELOPMENT OF CORD BLOOD-DERIVED, TRYPTASE-POSITIVE MAST-CELLS IN THE PRESENCE OF HUMAN NASAL POLYP FIBROBLASTS 1992
LEUKOTRIENE-B4 IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA 1992
PROFILE OF EOSINOPHIL CYTOKINE RESPONSES IN HYPEREOSINOPHILIC SYNDROME (HES) - LACK OF EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1992
REGULATION OF PROTEASE AND CYTOKINE EXPRESSION IN A HUMAN MAST-CELL LINE (HMC-1) - EFFECT OF NASAL POLYP STRUCTURAL CELL-DERIVED CONDITIONED MEDIA 1992
COMPARISON OF IMMUNOTHERAPY (POLLINEX-R) AND AQUEOUS STEROID NASAL SPRAY (RHINOCORT) IN RAGWEED POLLEN-INDUCED RHINOCONJUNCTIVITIS 1989
EPITHELIAL-CELLS DERIVED FROM NASAL POLYPS AND INFERIOR TURBINATE TISSUES PRODUCE NEUTROPHILIC AND MONOCYTIC DIFFERENTIATING ACTIVITY 1989
FIBROBLASTS DERIVED FROM HUMAN NASAL TISSUES PRODUCE NEUTROPHILIC AND BASOPHILIC DIFFERENTIATING FACTORS INCLUDING GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) 1989
GUSTATORY RHINITIS - A SYNDROME OF FOOD-INDUCED RHINORRHEA 1989
LACK OF CORRELATION BETWEEN METHACHOLINE AND ADENOSINE-MONOPHOSPHATE (AMP) AIRWAY RESPONSIVENESS 1989
NASAL SECRETIONS IN RECURRENT SINUSITIS 1989
SYNERGISTIC EFFECTS OF NERVE GROWTH-FACTOR (NGF) AND GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) ON HUMAN GRANULOPOIESIS - SPECIFIC ENHANCEMENT OF BASOPHIL MAST-CELL (BMC) DIFFERENTIATION 1989
123 T-Cell mediated colony stimulating activity by nerve growth factor 1988
187 Treatment of CMV enterocolitis with DHPG in an infant with aids 1988
452 A possible unique basophil differentiation factor derived from T-cells and nasal polyp epithelium 1988
94 Improvements in airway responsiveness and asthma during pregnancy: Relationship to serum progesterone 1988
ENHANCED STIMULATION OF GROWTH AND DIFFERENTIATION OF BASOPHIL MAST-CELL AND EOSINOPHIL PROGENITORS FROM ALLERGIC INDIVIDUALS BY ALLERGIC NASAL MUCOSAL CONDITIONED MEDIUM 1987
INHALED LEUKOTRIENE D4 DOES NOT CAUSE A LATE ASTHMATIC RESPONSE IN ATOPIC SUBJECTS 1987
THE EFFECTS OF BASOPHIL MAST AND EOSINOPHIL CELL COLONY STIMULATING ACTIVITIES DERIVED FROM HUMAN NASAL POLYP EPITHELIAL SCRAPINGS ARE T-CELL DEPENDENT 1987
UNUSUAL VARICELLA INFECTION AND SPONTANEOUS REMISSION OF LYMPHOCYTIC INTERSTITIAL PNEUMONITIS (LIP) IN PEDIATRIC AIDS 1987
VARIABILITY OF NEBULIZER OUTPUT DURING STANDARD METHODS OF INHALATION 1987
ARE METHACHOLINE TESTS USEFUL IN CLINICAL-PRACTICE 1986
BASOPHIL MAST-CELL PROGENITORS AND GROWTH-FACTORS IN HUMAN NASAL-MUCOSA 1986
SERUM LYMPHOCYTOTOXINS (LCA), NEURONAL ANTIBODIES (NA) AND NEUROCOGNITIVE IMPAIRMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS 1986
213 Rate of degradation of methacholine under various storage conditions 1983
217 The diagnostic significance of increased bronchial responsiveness to methacholine in subjects with rhinitis 1983
279 Nickel antibodies react with a Ni/HSA complex 1983
ALLERGEN-INDUCED INCREASE IN NON-ALLERGIC AIRWAY RESPONSIVENESS TO HISTAMINE 1980
BRONCHIAL PROVOCATION TESTS - EVALUATION OF 2 TECHNIQUES OF AEROSOL INHALATION 1980
PREFERENTIAL DEPOSITION OF ALLERGEN - INFLUENCE ON SEVERITY AND PATTERN OF RESPONSE 1980
COMPARISONS OF SUBUNIT AND WHOLE VIRUS INFLUENZA VACCINES 1979
Early-life Upper Airway Microbiota are Associated with Decreased Lower Respiratory Tract Infections.. S0091-6749(24)01189-8. 2024
Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis. 154:340-354. 2024
Antibiotics taken within the first year of life are linked to infant gut microbiome disruption and elevated atopic dermatitis risk. 154:131-142. 2024
Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials. 154:996-1007. 2024
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent. 153:1621-1633. 2024
Food sensitization and cardiovascular mortality: An intriguing association in need of further study. 153:1163-1165. 2024
Descriptive analysis of oral food challenge outcomes from a multicentre cohort study. 153:AB37-AB37. 2024
Efficacy and safety of leukotriene receptor antagonists as an add-on therapy for the management of antihistamine refractory chronic urticaria: a systematic review and meta-analysis. 153:AB70-AB70. 2024
Systemic Treatments for Atopic Dermatitis: Systematic Review and Network MetaAnalysis of Randomized Trials. 153:AB69-AB69. 2024
The risk of severe adverse reactions to neffy intranasal epinephrine spray. 153:535-536. 2024
Topical Treatments for Atopic Dermatitis: Systematic Review and Network Meta-Analysis of Randomized Trials. 153:AB80-AB80. 2024
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. 152:1470-1492. 2023
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. 152:1493-1519. 2023
Refashioning dexpramipexole: A new horizon in eosinophilic asthma?. 152:1092-1094. 2023
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. 152:309-325. 2023
Anti-epithelial-derived cytokines for severe asthma: Systematic review and meta-analysis. 151:1566-1576. 2023
Effects of Prescription Medications on Clinical Outcomes in Adults Presenting with Anaphylaxis. 151:AB11-AB11. 2023
Mild-moderate atopic dermatitis controlled by medication exhibits similar bacterial taxa to controls, but strain-level effects and virome disruption persist. 151:AB231-AB231. 2023
The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. 151:386-398. 2023
Wheat-Induced Anaphylaxis in Pediatric Patients from the Cross-Canada Anaphylaxis Registry (C-CARE): Clinical Characteristics and Management. 151:AB6-AB6. 2023
Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms. 151:147-158. 2023
Drug allergy: A 2022 practice parameter update. 150:1333-1393. 2022
Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis. 150:1447-1459. 2022
Heterogeneity, subsets, and plasticity of T follicular helper cells in allergy. 150:990-998. 2022
Wheeze trajectories: Determinants and outcomes in the CHILD Cohort Study. 149:2153-2165. 2022
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis. 149:1286-1295. 2022
Oral Food Challenge Outcomes at McMaster University Over Two-years. 149:AB111-AB111. 2022
Staphylococcus aureus Disruption of Keratinocytes in Atopic Dermatitis. 149:AB230-AB230. 2022
Reply. 149:452-453. 2022
Nudging the bilirubin dial to protect against asthma development. 148:78-79. 2021
Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines. 147:1561-1578. 2021
Interrupting reactivation of immunologic memory diverts the allergic response and prevents anaphylaxis. 147:1381-1392. 2021
Polygenic risk score for atopic dermatitis in the Canadian population. 147:406-409. 2021
Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis. 146:1302-1334. 2020
Multiomic approaches to study B cells: Sequencing, cytometry, imaging, and beyond. 146:456-457. 2020
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen. 145:1585-1597. 2020
Toward personalization of asthma treatment according to trigger factors. 145:1529-1534. 2020
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?. 145:1153-1156. 2020
Blockade of IL-4/IL-13 Signaling Reprograms IgE-Mediated Immune Memory Responses and Inhibits Anaphylaxis. 145:AB338-AB338. 2020
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. 145:70-80.e3. 2020
Prenatal exposure to traffic-related air pollution, the gestational epigenetic clock, and risk of early-life allergic sensitization. 144:1729-1731.e5. 2019
Reduced genetic potential for butyrate fermentation in the gut microbiome of infants who develop allergic sensitization. 144:1638-1647.e3. 2019
Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition. 144:1122-1125.e6. 2019
Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma. 144:788-795.e1. 2019
Human BCR analysis of single-sorted, putative IgE+ memory B cells in food allergy. 144:336-339.e6. 2019
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. 144:135-143.e6. 2019
An update on immunologic mechanisms in the respiratory mucosa in response to air pollutants. 143:1989-2001. 2019
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. 143:864-879. 2019
Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy. 143:1087-1099.e4. 2019
Correlation of Clinical Atopic Dermatitis Scores with Levels of Eosinophil Progenitors in Skin after Intradermal Allergen Challenge. 143:AB66-AB66. 2019
The IgE memory reservoir in food allergy. 142:1441-1443. 2018
CD8+CD28−CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?. 141:2220-2233.e4. 2018
Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma. 141:1529-1532.e8. 2018
Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge. 141:1495-1498.e9. 2018
Sputum autoantibodies in patients with severe eosinophilic asthma. 141:1269-1279. 2018
Inhibition of ABCC4 potentiates combination beta agonist and glucocorticoid responses in human airway epithelial cells. 141:1127-1130.e5. 2018
Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study. 141:601-607.e8. 2018
Lifelong memory responses perpetuate humoral T H 2 immunity and anaphylaxis in food allergy. 140:1604-1615.e5. 2017
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. 140:950-958. 2017
Asthmatic subjects with allergy have elevated levels of IgE+ B cells in the airways. 140:590-593.e9. 2017
Treatment with grass allergen peptides improves symptoms of grass pollen–induced allergic rhinoconjunctivitis. 140:486-496. 2017
Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunction. 139:771-779.e10. 2017
Controlled diesel exhaust and allergen coexposure modulates microRNA and gene expression in humans: Effects on inflammatory lung markers. 138:1690-1700. 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. 138:1051-1059. 2016
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. 138:367-374.e2. 2016
Expression of activation markers in circulating basophils and the relationship to allergen-induced bronchoconstriction in subjects with mild allergic asthma. 137:936-938.e7. 2016
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. 137:75-86.e8. 2016
Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent. 136:1636-1644. 2015
Timing is everything: Targeting IgE to reduce asthma exacerbation risk. 136:1486-1487. 2015
Reply. 136:1423-1425. 2015
Predicting asthma outcomes. 136:829-836. 2015
Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. 136:952-961. 2015
Lineage-specific regulation of allergic airway inflammation by the lipid phosphatase Src homology 2 domain–containing inositol 5-phosphatase (SHIP-1). 136:725-736.e2. 2015
Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases. 136:571-580.e3. 2015
Prevalence and characteristics of asthma in the aquatic disciplines. 136:588-594. 2015
MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. 136:462-473. 2015
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. 135:1457-1464.e4. 2015
Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. 135:1594-1602. 2015
Prenatal adverse life events increase the risk for atopic diseases in children, which is enhanced in the absence of a maternal atopic predisposition. 134:160-169.e7. 2014
Birth cohorts in asthma and allergic diseases: Report of a NIAID/NHLBI/MeDALL joint workshop. 133:1535-1546. 2014
Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. 133:1142-1148.e5. 2014
Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. 133:777-783.e4. 2014
Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma. 133:696-703. 2014
Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis. 133:751-758. 2014
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. 132:1086-1096.e5. 2013
Inhaled allergen bronchoprovocation tests. 132:1045-1055.e6. 2013
Asthma in the real world. 132:70-71. 2013
What is an “eosinophilic phenotype” of asthma?. 132:81-83. 2013
A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. 131:752-762.e7. 2013
A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial of Standardized Short Ragweed (RW) Sublingual Allergy Immunotherapy Liquid Extract (RW-SAIL) in Adult Subjects with Ragweed-Induced Allergic Rhinoconjunctivitis. 131:AB146-AB146. 2013
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. 131:461-467.e5. 2013
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. 132:1295-1302. 2013
Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study. 131:103-109.e7. 2013
Gut microbiota diversity and atopic disease: Does breast-feeding play a role?. 131:247-248. 2013
IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. 131:187-200.e8. 2013
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. 130:1049-1062. 2012
Overall prevalence of self-reported food allergy in Canada. 130:986-988. 2012
Novel targeted therapies for eosinophilic disorders. 130:563-571. 2012
Serum periostin as a marker of TH2-dependent eosinophilic airway inflammation. 130:655-656. 2012
Sputum cell counts and methacholine hyperresponsiveness as asthma outcomes. 130:823-823. 2012
Methacholine test and the diagnosis of asthma. 130:556-556. 2012
The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction. 130:535-539.e3. 2012
Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations. 129:1280-1281. 2012
Effect of precautionary statements on the purchasing practices of Canadians directly and indirectly affected by food allergies. 129:1401-1404. 2012
The airway epithelium in childhood asthma. 129:998-999. 2012
The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. 129:1116-1125.e6. 2012
Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes. 129:AB368-AB368. 2012
Possession of epinephrine auto-injectors by Canadians with food allergies. 128:426-428. 2011
Therapeutic strategies to reduce asthma exacerbations. 128:257-263. 2011
Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice. 127:1552-1561.e1. 2011
Reply. 127:1643-1645. 2011
How representative are clinical study patients with allergic rhinitis in primary care?. 127:920-926.e1. 2011
A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada (vol 125, pg 1327, 2010). 127:840-840. 2011
Reply. 127:834-834. 2011
Maternal allergy modulates cord blood hematopoietic progenitor Toll-like receptor expression and function. 127:447-453. 2011
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. 127:89-97.e14. 2011
Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently. 127:288-289. 2011
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article. 127:49-56.e11. 2011
Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA): A summary report. 126:1119-1128.e12. 2010
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. 126:926-938. 2010
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. 126:466-476. 2010
Immune mechanisms of sublingual immunotherapy: Are oral Langerhans cells the masters of tolerance?. 126:646-647. 2010
Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma. 126:404-406. 2010
Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. 126:133-139. 2010
A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada. 125:1327-1335. 2010
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples. 125:1161-1163.e4. 2010
Evidence for neuronal expression of functional Fc (ε and γ) receptors. 125:757-760. 2010
Overall asthma control: The relationship between current control and future risk. 125:600-608.e6. 2010
Reply. 125:765-765. 2010
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. 125:349-356.e13. 2010
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma. 124:1217-1221. 2009
Cats and dogs and the risk of atopy in childhood and adulthood. 124:745-750.e4. 2009
Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma. 124:397-403. 2009
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. 124:307-314.e2. 2009
CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. 123:472-478.e1. 2009
Step-up therapy in uncontrolled asthma: Choices and outcomes. 123:122-123. 2009
Epidemiology of asthma exacerbations. 122:662-668. 2008
Modulation of β1-integrins on hemopoietic progenitor cells after allergen challenge in asthmatic subjects. 122:803-810. 2008
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. 122:544-549. 2008
Evaluation of 2 interactive voice-response telephone versions of health-related quality-of-life questionnaires. 122:654-655. 2008
Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)–1/TIM4 interaction as a therapeutic strategy in a dendritic cell–induced peanut allergy model. 122:55-61.e7. 2008
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: Effectiveness of early intervention with budesonide in mild persistent asthma. 121:1167-1174. 2008
Cigarette smoking and allergic sensitization: A 32-year population-based cohort study. 121:38-42.e3. 2008
Understanding the September asthma epidemic. 120:526-529. 2007
The September epidemic of asthma exacerbations in children: A search for etiology (vol 115, pg 132, 2005). 120:365-365. 2007
The September epidemic of asthma hospitalization: School children as disease vectors (vol 117, pg 557, 2006). 120:47-47. 2007
Acute asthma intervention: Insights from the STAY study. 119:1332-1336. 2007
Interactions between breast-feeding, specific parental atopy, and sex on development of asthma and atopy. 119:1359-1366. 2007
Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. 119:848-854. 2007
Update on the current status of peptide immunotherapy. 119:906-909. 2007
Adiposity, asthma, and airway inflammation. 119:634-639. 2007
Effectiveness of, Adherence to and Satisfaction with Montelukast Treatment in Allergic Rhinitis Patients with Uncontrolled Asthma Symptoms while on Treatment with Low Dose Inhaled Corticosteroids. 119:S244-S245. 2007
Reply. 118:970-971. 2006
Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. 118:699-704. 2006
Problems with using exhaled nitric oxide to guide asthma treatment. 117:1511-1511. 2006
Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. 117:1008-1013. 2006
Eosinophilic bronchitis in asthma: A model for establishing dose-response and relative potency of inhaled corticosteroids. 117:989-994. 2006
The September epidemic of asthma hospitalization: School children as disease vectors. 117:557-562. 2006
Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. 116:285-291. 2005
Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. 116:221-223. 2005
Expression of functional cysteinyl leukotriene receptors by human basophils. 116:80-87. 2005
Different profiles of T-cell IFN-γ and IL-12 in allergen-induced early and dual responders with asthma. 115:1004-1009. 2005
Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy. 115:745-750. 2005
Clinical outcomes and adverse effect monitoring in allergic rhinitis. 115:S390-S413. 2005
Progenitor egress from the bone marrow after allergen challenge: Role of stromal cell–derived factor 1α and eotaxin. 115:501-507. 2005
Ciclesonide is effective in protecting against exercise-induced bronchoconstriction. 115:S1-S1. 2005
Early intervention with budesonide in recent onset mild persistent asthma in children: START trial results. 115:S58-S58. 2005
Qualitative study on the barriers to adherence to inhaled corticosteroids among iranian asthmatic patients. 115:S212-S212. 2005
Recruitment of CD4 cells during peptide-induced isolated late asthmatic reactions is associated with increased TARC expression. 115:S273-S273. 2005
Treatment of bee venom allergic subjects with phospholipase A2 T Cell epitope peptides results in iincreased expression of mRNA encoding suppressor of cytokine signalling (SOCS) 3 and a transient increase in allergen-specific IgG/G4. 115:S108-S108. 2005
Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. 115:95-102. 2005
The September epidemic of asthma exacerbations in children: A search for etiology. 115:132-138. 2005
Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. 114:629-637. 2004
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. 114:248-253. 2004
Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. 114:73-79. 2004
Allergen peptide immunotherapy in humans inhibits allergen-induced proliferation of CD4+ T cells but does not affect suppressive activity of CD4+CD25+ T cells*1. 113:S254-S254. 2004
Allergen-based peptide immunotherapy is associated with functional modifications in allergen-specific T-cell subpopulations*1. 113:S255-S255. 2004
Allergen-specific cytokine production in human peripheral blood mononuclear cells from peanut-allergic subjects in vitro*1. 113:S252-S252. 2004
Cat allergen sensitivity in HLA DR1-transgenic mice*1A model to investigate mechanisms of prophylactic allergen tolerance. 113:S94-S95. 2004
Effects of intranasal fluticasone and salmeterol on allergen-induced nasal inflammation and nasal electrical potential in allergic rhinitis*1. 113:S197-S197. 2004
Evidence for a Th2-to-Th1 shift in IL-4 deficient mice in response to chronic house dust mite exposure*1. 113:S164-S164. 2004
Isolated late asthmatic reactions provoked by inhalation of T-cell peptide epitopes are associated with bronchial mucosal infiltration of CD4+ T cells and increased airway hyperresponsiveness*1. 113:S174-S174. 2004
Peptide-based allergen immunotherapy is associated with improvements in symptoms of rhinitis*1. 113:S107-S107. 2004
The effect of treatment with HLA-DR based T cell peptides derived from phospholipase A2 on late-phase skin reactions and T cell function in subjects with mild honeybee allergy*1. 113:S112-S112. 2004
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. 112:331-338. 2003
Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation. 112:37-44. 2003
Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. 111:1076-1086. 2003
Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. 111:714-719. 2003
A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. 111:484-490. 2003
The role of T lymphocytes in the pathogenesis of asthma. 111:450-463. 2003
Allergen-derived T-cell peptide immunotherapy in allergic asthmatic individuals is associated with induction of CD4+ IFN-gamma+/CD4+CD25+ T cells and enhanced expression of TGF-beta and Notch-1 ligands at sites of cutaneous allergen challenge. 111:S197-S197. 2003
Budesonide enhancement of eosinophil differentiation in vitro does not involved IL-5Rα overexperesion or increased p38 MAP kinase activation. 111:S266-S266. 2003
Effect of HLA-DR-based T cell peptides derived from phospholipase A2 on late-phase skin reactions and T cell function in subjects with mild honeybee allergy. 111:S198-S198. 2003
IL-10 inhibits allergen-specific Th2 chemokine production but not chemokine receptor expression by human peripheral blood mononuclear cells in ragweed allergic subjects. 111:S285-S285. 2003
Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. 111:S81-S81. 2003
Late asthmatic reactions provoked by intradermal, but not inhaled, allergen-derived T-cell peptides induce “Tolerance” to subsequent antigen challenge. 111:S281-S281. 2003
Neural stem cell cytotoxic activity in cerebrospinal fluid from a patient with end-stage neuropsychiatric systemic lupus erythematosus. 111:S318-S318. 2003
Adverse effects of β-agonists. 110:S322-S328. 2002
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol. 110:325-325. 2002
Risk factors for hospital admission for asthma from childhood to young adulthood: A longitudinal population study. 110:220-227. 2002
The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. 110:96-101. 2002
Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. 110:174-182. 2002
Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. 109:789-793. 2002
Reply. 109:575-576. 2002
Significant variability in response to inhaled corticosteroids for persistent asthma. 109:410-418. 2002
The trials and tribulations of anti–IL-5 …. 109:575-575. 2002
IL-10 production in circulating T cells differs between allergen-induced isolated early and dual asthmatic responders. 109:281-286. 2002
Retinoic acid modulates IL-5 receptor expression and selectively inhibits eosinophil-basophil differentiation of hemopoietic progenitor cells. 109:307-313. 2002
Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. 109:162-170. 2002
The trials and tribulations of IL-5, eosinophils, and allergic asthma. 108:503-508. 2001
Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or TH2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. 108:394-401. 2001
Proliferation and release of IL-5 and IFN-γ by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non–cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1. 108:349-356. 2001
Normally suppressing CD40 coregulatory signals delivered by airway macrophages to TH2 lymphocytes are defective in patients with atopic asthma. 107:863-870. 2001
Coronary and laryngeal spasm provoked by methacholine inhalation. 107:392-393. 2001
Bone marrow events in animal models of allergic inflammation and hyperresponsiveness. 106:S235-S241. 2000
Determinants of the immune-inflammatory response in allergic airway inflammation: Overview of antigen presentation and cellular activation. 106:S206-S212. 2000
Systemic aspects of allergic disease: Bone marrow responses. 106:S242-S246. 2000
A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. 106:638-644. 2000
Immunofluorescence analysis of cytokine and granule protein expression during eosinophil maturation from cord blood–derived CD34+ progenitors. 105:1178-1184. 2000
Blood eosinophils from atopic donors express messenger RNA for the α, β, and γ subunits of the high-affinity IgE receptor (FcϵRI) and intracellular, but not cell surface, α subunit protein. 105:309-317. 2000
Carbon dioxide inhalation challenges in idiopathic environmental intolerance.. 105:358-363. 2000
Erratum: Increased numbers of both airway basophils and mast cells after allergen inhalation in atopic asthmatics (Journal of Allergy and Clinical Immunology (January)). 105:231. 2000
Sputum in asthma: Color versus cell counts. 105:182-183. 2000
Concepts of establishing clinical bioequivalence of chlorofluorocarbon and hydrofluoroalkane β-agonists☆☆☆★. 104:s243-s245. 1999
Reduced expression of hemopoietic cytokine receptors on cord blood progenitor cells in neonates at risk for atopy.. 104:370-375. 1999
Reduced expression of hemopoietic cytokine receptors on cord blood progenitor cells in neonates at risk for atopy☆☆☆★. 104:370-375. 1999
Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma. 104:502-503. 1999
Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma☆☆☆★★★. 104:502-503. 1999
Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. 104:364-369. 1999
Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire☆☆☆★. 104:364-369. 1999
Repeatability of allergen-induced airway inflammation☆☆☆★. 104:66-71. 1999
Introduction. 102. 1998
Measuring efficacy and safety of different inhaled corticosteroid preparations☆☆☆★. 102:879-886. 1998
Asthma and Allergy: A Festschrift in Honor of Jerry Dolovich, MD☆☆☆★★★. 102:S73-S73. 1998
Asthma pathogenesis and allergen-induced late responses☆☆☆★. 102:S85-S89. 1998
The origins of basophils and eosinophils in allergic inflammation☆☆☆★. 102:S74-S76. 1998
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. 102:177-183. 1998
Quality of life questionnaires: Does statistically significant = clinically important?. 102:16-17. 1998
The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs☆☆☆★★★. 101:342-348. 1998
Impact of upper respiratory allergic diseases on quality of life. 101:S386-S391. 1998
Incidence of latex sensitization among latex glove users.. 101:171-178. 1998
Incidence of latex sensitization among latex glove users☆☆☆★★★. 101:171-178. 1998
Measuring quality of life in children with rhinoconjunctivitis. 101:163-170. 1998
Measuring quality of life in children with rhinoconjunctivitis☆☆☆★★★. 101:163-170. 1998
Stem cell factor in nasal polyposis and allergic rhinitis: Increased expression by structural cells is suppressed by in vivo topical corticosteroids. 100:389-399. 1997
Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model☆☆☆★★★. 100:65-70. 1997
IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease. 99:563-569. 1997
Measuring health-related quality of life in rhinitis☆☆☆★. 99:S742-S749. 1997
Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4–receptor antagonist cinalukast☆☆☆★. 99:210-215. 1997
Interpretation of rhinoconjunctivitis quality of life questionnaire data. 98:843-845. 1996
380 Increases in circulating CD34+ hemopoietic progenitors in allergen-induced late asthmatic responses. 97:277-277. 1996
458 Increased bone marrow progenitor growth after allergen challenge in dogs depends on a serum factor. 97:297-297. 1996
708 IL-5 secretion by allergen-specific CD4+ cells in short-term culture: dissociation from allergen-induced proliferation and dependence on B7-2 co-stimulation. 97:359-359. 1996
Regular use of inhaled albuterol and the allergen-induced late asthmatic response. 96:44-49. 1995
Regularly inhaled β-agonists in stable asthma. 96:137-137. 1995
Reproducibility of allergen-induced early and late asthmatic responses. 95:1191-1195. 1995
Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children. 95:548-556. 1995
Basophil and eosinophil differentiation in allergic reactions. 94:1135-1141. 1994
Sodium cromoglycate eye drops: Regular versus “as needed” use in the treatment of seasonal allergic conjunctivitis. 94:36-43. 1994
Immunocytochemical detection of granulocyte-macrophage colony-stimulating factor and eosinophil cationic protein in sputum cells. 93:945-947. 1994
Nasal polyps: Effects of seasonal allergen exposure. 93:567-574. 1994
Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. 93:413-423. 1994
Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: Further exploration of “as needed” use. 92:66-72. 1993
Beclomethasone given after the early asthmatic response inhibits the late response and the increased methacholine responsiveness and cromolyn does not. 91:1163-1168. 1993
Quality of life of subjects with occupational asthma. 91:1121-1127. 1993
IMMUNOCYTOCHEMICAL LOCALIZATION OF GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR IN CANINE BRONCHOALVEOLAR LAVAGE CELLS. 91:206-206. 1993
The relationship between late asthmatic responses and antigen-specific immunoglobulin. 90:661-669. 1992
Relationships of bronchial responsiveness assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children. 90:376-385. 1992
The effects of H2-receptor antagonists on exercise refractoriness in asthma. 90:125-126. 1992
Clinical evaluation of the efficacy and safety of noberastine, a new H1 antagonist, in seasonal allergic rhinitis: A placebo-controlled, dose-response study. 88:926-934. 1991
In re: Van Bever HP, Stevens WJ. (JACI 1990;86:141–146). 88:283-284. 1991
Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. 87:483-489. 1991
The use of reservoir devices for the simultaneous delivery of two metered-dose inhalers. 87:599-599. 1991
141 Human upper airway epithelial cell and fibroblast IL-8 production and its modulation by steroids. 87:174-174. 1991
263 Isolation and functional studies of human nasal polyp mast cell populations. 87:205-205. 1991
440 Changes in the cellular profile of inducedsputum after allergen-induced asthmatic responses. 87:249-249. 1991
A double-blind comparison of intranasal budesonide with placebo for nasal polyposis. 86:946-953. 1990
Aqueous beclomethasone diproprionate nasal spray: Regular versus “as required” use in the treatment of seasonal allergic rhinitis. 86:380-386. 1990
Urinary leukotriene E4 levels during early and late asthmatic responses†. 86:211-220. 1990
Abnormal nasal glandular secretion in recurrent sinusitis. 86:10-18. 1990
Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis. 85:606-611. 1990
Hematopoietic growth factor production by cultured cells of human nasal polyp epithelial scrapings: Kinetics, cell source, and relationship to clinical status. 83:1091-1100. 1989
Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine. 83:913-920. 1989
Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. 83:627-633. 1989
LATE-PHASE AIRWAY REACTION AND INFLAMMATION. 83:521-524. 1989
Late-phase airway reaction and inflammation. 83:521-524. 1989
Increasing asthma mortality—Fact or artifact?. 82:957-960. 1988
Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis. 82:670-675. 1988
Allergic rhinitis nasal mucosal conditioned medium stimulates growth and differentiation of basophil/mast cell and eosinophil progenitors from atopic blood. 81:1149-1154. 1988
Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis.. 81:570-574. 1988
Phenol amplifies complement-fixing activity and induces IgG-precipitating activity in grain-dust extract. 81:557-563. 1988
Allergen-induced airway hyperresponsiveness. 81:119-127. 1988
Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma. 80:839-843. 1987
INVIVO AND INVITRO HUMAN AIRWAY RESPONSIVENESS TO LEUKOTRIENE-D4 IN PATIENTS WITHOUT ASTHMA. 80:688-694. 1987
In vivo and in vitro human airway responsiveness to leukotriene D4 in patients without asthma. 80:688-694. 1987
Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma. 80:612-621. 1987
Asthma morbidity and mortality: New Zealand. 80:383-388. 1987
Asthma mortality: A review of recent experience in New Zealand. 80:319-325. 1987
Patients at risk for dying of asthma: New Zealand experience. 80:477-481. 1987
The pathogenesis of severe asthma: A consensus report from the workshop on pathogenesis. 80:428-437. 1987
A comparison of budesonide and beclomethasone dipropionate nasal aerosols in ragweed-induced rhinitis. 79:887-892. 1987
Polyethylene glycol-modified ragweed extract: Comparison of two treatment regimens. 78:851-856. 1986
The origin of airway hyperresponsiveness. 78:825-832. 1986
Airway responses to hyperventilation of cold dry air: Duration of protection by cromolyn sodium. 78:387-391. 1986
Workshop 4: The role of bronchoprovocation. 78:517-524. 1986
Workshop 6: Compliance factors. 78:529-533. 1986
Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients+. 78:365-371. 1986
Heterogeneity of metachromatic cells in human nose: Significance of mucosal mast cells. 76:695-702. 1985
Increased numbers of circulating basophil progenitors in atopic patients. 76:466-472. 1985
Transport abnormalities during intestinal anaphylaxis in the rat: Effect of antiallergic agents. 76:498-503. 1985
An anti-inflammatory drug (BW755C) inhibits airway hyperresponsiveness induced by ozone in dogs. 76:162-166. 1985
Mediators, airway responsiveness, and asthma. 76:272-276. 1985
The effect of inhaled hexamethonium bromide and atropine sulphate on airway responsiveness to histamine. 76:97-103. 1985
Asymptomatic bronchial hyperresponsiveness in rhinitis. 75:573-577. 1985
Polyethylene glycol-modified ragweed pollen extract in rhinoconjunctivitis. 75:578-585. 1985
Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. 75:25-30. 1985
Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. 71:399-406. 1983
Prolonged asthmatic responses to inhaled methacholine. 71:357-362. 1983
Mast cell heterogeneity: derivation and function, with emphasis on the intestine. 70:407-412. 1982
Cold air induced asthma: Relationship to non-specific bronchial responsiveness to methacholine. 69:50. 1982
Occupational asthma caused by nickel sulfate. 69:55-59. 1982
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. 68:347-355. 1981
Standardization of inhalation provocation tests: Influence of nebulizer output, particle size, and method of inhalation. 67:156-161. 1981
Asthma caused by occupational exposure to a furan-based binder system. 66:458-463. 1980
Guidelines for the methodology of exercise challenge testing of asthmatics. 64:642-645. 1979
Bronchial responsiveness to inhaled histamine and exercise. 63:315-320. 1979
Sodium cromoglycate in ragweed-allergic conjunctivitis. 59:437-439. 1977
Late cutaneous allergic responses in isolated IgE-dependent reactions. 52:38-46. 1973

has subject area

1107 Immunology (FoR)
Allergy (Science Metrix)

Journal of Allergy and Clinical Immunology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)